Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle
about
The cell biology of malaria infection of mosquito: advances and opportunitiesHigh resolution microscopy reveals an unusual architecture of the Plasmodium berghei endoplasmic reticulumStage-Specific Changes in Plasmodium Metabolism Required for Differentiation and Adaptation to Different Host and Vector EnvironmentsIdentification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial CompoundsStudies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysisKAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission.Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.Proteomic analysis of Plasmodium in the mosquito: progress and pitfalls.A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose TransportersMalaria parasite pre-erythrocytic infection: preparation meets opportunity.GLUT1-mediated glucose uptake plays a crucial role during Plasmodium hepatic infection.Membrane transport in the malaria parasite and its host erythrocyte.The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.The biology of sexual development of Plasmodium: the design and implementation of transmission-blocking strategies.The Promise of Systems Biology Approaches for Revealing Host Pathogen Interactions in Malaria.Targeting Channels and Transporters in Protozoan Parasite Infections.
P2860
Q27024179-1F72BD41-F397-48BF-B187-7AD3B23123FAQ27973738-C5356589-B072-4B73-BBD9-3CE9622288FCQ28468534-BA35C97A-275C-42E9-8E6A-7C31A9622B21Q28546576-3E54141A-46DA-48E5-A92A-1510414AEBFCQ30041886-92BEA2B0-BA01-466D-9F35-1468DCDA40F5Q34057433-A0D9006A-9DC0-48FE-BA0B-64057DAD051AQ35102950-532838AE-FE3B-4930-AC28-E77726A73383Q35878689-B31A4260-0192-4318-B6E5-365CAE5B3DFBQ36159362-60A122A5-4BB4-4C2E-9F5A-2DBFE55967C6Q36162383-02714C5E-8432-4BB5-AF53-F7D96CB5C35BQ37533146-414172A9-8106-4D31-88D0-FAE617B52E1FQ37631769-F4E02FE3-0D6C-4454-BD68-9D1330E1FE91Q38170172-F0D8269C-CF72-4523-9A15-6DCC128DBA70Q41066112-B69DE6A2-655B-45B5-9AEB-0BF0D997E026Q42562371-0C20EE37-D4EF-44BD-8C6D-2F5DA920FE2BQ47133377-75142743-A031-4549-9CA9-A93AFF160D6AQ52594992-440F5F06-4A9B-4CFA-A165-F69B3A233C72
P2860
Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of a selective inhibitor t ...... s of the parasite's life cycle
@ast
Use of a selective inhibitor t ...... s of the parasite's life cycle
@en
type
label
Use of a selective inhibitor t ...... s of the parasite's life cycle
@ast
Use of a selective inhibitor t ...... s of the parasite's life cycle
@en
prefLabel
Use of a selective inhibitor t ...... s of the parasite's life cycle
@ast
Use of a selective inhibitor t ...... s of the parasite's life cycle
@en
P2093
P2860
P50
P356
P1476
Use of a selective inhibitor t ...... s of the parasite's life cycle
@en
P2093
Christophe Morin
Elvira T Derbyshire
Robert E Sinden
Ursula Straschil
Zhengyao Xu
P2860
P304
P356
10.1128/AAC.01739-10
P407
P50
P577
2011-03-14T00:00:00Z